Adult: For the treatment of steroid-responsive inflammation of bulbar and palpebral conjunctiva, cornea, and anterior segment of the globe: As 0.1% eye drops susp: Instil 1-2 drops into the conjunctival sac 2-4 times daily; may be increased to 2 drops hourly or 1 drop 4 hourly during the initial 24-48 hours of treatment. As 0.25% eye drop susp: Instil 1 drop into the conjunctival sac 2-4 times daily; may be increased to 1 drop 4 hourly during the initial 24-48 hours of treatment. As 0.1% ointment: Apply small amount or approx 1/2 inch ribbon to the conjunctival sac 1-3 times daily; may be increased to 4 hourly during the initial 24-48 hours of treatment. Re-evaluate therapy if symptoms do not improve after 2 days. As 0.1% fluorometholone acetate eye drop susp: Instil 1-2 drops into the conjunctival sac 4 times daily; may be increased to 2 drops 2 hourly during the initial 24-48 hours of treatment. Re-evaluate therapy if symptoms do not improve after 14 days. Child: ≥2 years Same as adult dose.
Viral diseases of the cornea and conjunctiva (e.g. epithelial herpes simplex keratitis [dendritic keratitis], vaccinia, varicella); mycobacterial eye infection, fungal disease of ocular structures, acute purulent untreated bacterial eye infections.
Patient with glaucoma; history of herpes simplex, undiagnosed red eye, disease causing thinning of corneal or scleral tissue. Use after cataract surgery. Avoid abrupt withdrawal (particularly in chronic conditions). Children. Pregnancy and lactation.
Significant: Posterior subcapsular cataract formation, corneal and scleral thinning leading to perforation, optic nerve damage, defects in visual acuity and fields of vision, delayed corneal wound healing, secondary ocular infection (e.g. fungal infection), increased intraocular pressure and/or glaucoma (prolonged use); increased incidence of bleb formation (after cataract surgery), blurred vision. Rarely, central serous chorioretinopathy. Eye disorders: Eye pain, irritation, pruritus, and swelling; transient burning and stinging sensation of eyes, ocular hyperaemia, eyelid oedema, mydriasis, increased lacrimation, foreign body sensation in the eyes, eye discharge. Gastrointestinal disorders: Dysgeusia. Immune system disorders: Hypersensitivity reaction. Skin and subcutaneous tissue disorders: Rash.
This drug may cause transient blurred vision; if affected, do not drive or operate machinery. Remove contact lenses before administration and wait at least 15 minutes prior to reinsertion.
Monitor intraocular pressure regularly particularly when used for ≥10 days and in patients with glaucoma; signs and symptoms of secondary infection. Perform frequent slit lamp microscopy particularly in patients with history of herpes simplex.
May delay the healing of ophthalmic tissue when used with ophthalmic NSAIDs. May increase the risk of systemic adverse effects with CYP3A4 inhibitors (e.g. cobicistat-containing agents, ritonavir).
Description: Fluorometholone is a synthetic corticosteroid that readily penetrates cells to induce the production of lipocortins, the proteins responsible for modulating the action of prostaglandins and leukotrienes. It also blocks the inflammatory response including oedema, capillary dilatation, leukocyte migration, and scar formation. Pharmacokinetics: Absorption: Mainly absorbed into the aqueous humour.
Ophthalmic susp: Store between 2-25°C. Do not freeze. Ophthalmic ointment: Store between 15-25°C.
S01BA07 - fluorometholone ; Belongs to the class of corticosteroids. Used in the treatment of inflammation of the eye.
Anon. Fluorometholone. AHFS Clinical Drug Information [online]. Bethesda, MD. American Society of Health-System Pharmacists, Inc. https://www.ahfscdi.com. Accessed 08/10/2020.Anon. Fluorometholone. Lexicomp Online. Hudson, Ohio. Wolters Kluwer Clinical Drug Information, Inc. https://online.lexi.com. Accessed 08/10/2020.Buckingham R (ed). Fluorometholone. Martindale: The Complete Drug Reference [online]. London. Pharmaceutical Press. https://www.medicinescomplete.com. Accessed 08/10/2020.Flarex (Novartis Pharmaceuticals [HK] Ltd). MIMS Hong Kong. http://www.mims.com/hongkong. Accessed 08/10/2020.Fluorometholone Solution/Drops (Pacific Pharma, Inc.). DailyMed. Source: U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/. Accessed 08/10/2020.FML Forte Suspension/Drops (Allergan, Inc.). DailyMed. Source: U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/. Accessed 08/10/2020.FML Liquifilm Ophthalmic 1 mg/mL Eye Drops, suspension (Allergan Ltd). MHRA. https://products.mhra.gov.uk/. Accessed 08/10/2020.FML Ointment (Allergan, Inc.). DailyMed. Source: U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/. Accessed 08/10/2020.Joint Formulary Committee. Fluorometholone. British National Formulary [online]. London. BMJ Group and Pharmaceutical Press. https://www.medicinescomplete.com. Accessed 08/10/2020.Novartis New Zealand Limited. Flucon 0.1% Eye Drops Suspension data sheet 30 July 2018. Medsafe. http://www.medsafe.govt.nz/. Accessed 08/10/2020.